Compugen to Present at Single Cell Genomics 2023 Meeting : v

/PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today...

Related Keywords

Tel Aviv , Israel , San Francisco , California , United States , Switzerland , Yvonne Naughton , Roy Granit , Nasdaq , Stock Exchange , Compugen , Corporate Communications , Compugen Ltd , Astrazeneca , Prnewswire Compugen Ltd , Single Cell Genomics , Novel Immune Checkpoint , High Resolution Spatial , Computational Discovery , Investor Relations ,